{"pmid":32203269,"title":"The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage.","text":["The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage.","Bone Marrow Transplant","Szer, Jeff","Weisdorf, Daniel","Querol, Sergio","Foeken, Lydia","Madrigal, Alejandro","32203269"],"journal":"Bone Marrow Transplant","authors":["Szer, Jeff","Weisdorf, Daniel","Querol, Sergio","Foeken, Lydia","Madrigal, Alejandro"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32203269","week":"202013|Mar 23 - Mar 29","doi":"10.1038/s41409-020-0873-x","source":"PubMed","weight":0,"_version_":1662090442993303552,"score":6.998814,"similar":[{"pmid":32180224,"title":"How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?","text":["How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat?","Br J Haematol","Dholaria, Bhagirathbhai","Savani, Bipin N","32180224"],"journal":"Br J Haematol","authors":["Dholaria, Bhagirathbhai","Savani, Bipin N"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32180224","week":"202012|Mar 16 - Mar 22","doi":"10.1111/bjh.16597","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1661542092007014401,"score":47.49637}]}